Trial Information

Summary: Osteoporosis Study for Men.

Osteoporosis in men represents an important, although long underestimated public health problem. At least 20 percent of cases of osteoporosis occur in men and may lead to bone fractures and height loss.

Diablo Clinical Research and Dr. Richard Weinstein are conducting a research study to compare the effectiveness of 2 treatments: a yearly infusion of zoledronic acid (Zometa®) versus a weekly oral dose of alendronate (Fosamax®).

You may qualify for the study if you:

• are a male aged 25 - 85
• have been diagnosed with osteoporosis

Qualified participants receive at no cost:

• All investigational medications
• Study-related physical examinations
• Bone density testing & X-rays
• Laboratory tests

To learn more,

If you would like to learn more about participating in this study, please send an e-mail message using the form below.